Sofinnova Investments, Inc. Amylyx Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.62 - $2.71 $11,401 - $19,072	-7,038 Reduced 2.29%	299,691 $569,000
Q1 2024 Aug 14, 2024	BUY	$2.71 - $19.57 $19,072 - $137,733	7,038 Added 2.35%	306,729 $871,000
Q1 2024 May 15, 2024	BUY	$2.71 - $19.57 $831,235 - $6 Million	306,729 New	306,729 $871,000
Q2 2022 Aug 15, 2022	BUY	$6.85 - $19.93 $598,559 - $1.74 Million	87,381 Added 87.38%	187,381 $3.61 Million
Q1 2022 May 16, 2022	BUY	$12.85 - $32.9 $1.29 Million - $3.29 Million	100,000 New	100,000 $1.29 Million

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $308M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.